The dominant-negative interplay between p53, p63 and p73: A family affair | Oncotarget
ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions - ScienceDirect
Sylvain Peuget, PhD on LinkedIn: Translating p53-based therapies for cancer into the clinic - Nature…
Model for the dominant-negative mechanism of TA-p73. A, inhibition of... | Download Scientific Diagram
Frontiers | The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
Dominant-negative effect of mutant p53 on wild-type p53. In response to... | Download Scientific Diagram
The role of mutant p53 in human cancer - Goh - 2011 - The Journal of Pathology - Wiley Online Library
Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation: Molecular Cell
The dominant-negative interplay between p53, p63 and p73: A family affair | Oncotarget
Frontiers | p53 mutation and deletion contribute to tumor immune evasion
Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer | Accounts of Chemical Research
Structure of p53 and dominant-negative behavior of mutant p53 toward... | Download Scientific Diagram
Inactivation of p53 in Human Keratinocytes Leads to Squamous Differentiation and Shedding via Replication Stress and Mitotic Slippage - ScienceDirect
The p53 pathway: positive and negative feedback loops | Oncogene
Title Role of p53 in Cancer Associated Gene Networks
Mutant TP53 posttranslational modifications: challenges and opportunities. - Abstract - Europe PMC
Role of p53 in breast cancer progression: An insight into p53 targeted therapy
Tumor Suppressor Protein p53 – Department of Chemistry, Faculty of Science,Hokkaido University Biological Chemistry Lab.
![PDF] Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b917d5b91b38642cf5a46bc1cb8cdea1921e2c4a/4-Figure1-1.png "PDF] Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors | Semantic Scholar")
PDF] Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors | Semantic Scholar
Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model | Gene Therapy
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53 | Journal of Ovarian Research | Full Text
Gene Regulation by p53 in Human Cancer System | Asian Pacific Journal of Cancer Biology
